Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

27.85USD
16 Feb 2018
Change (% chg)

$0.07 (+0.25%)
Prev Close
$27.78
Open
$27.69
Day's High
$28.71
Day's Low
$27.69
Volume
115,854
Avg. Vol
139,916
52-wk High
$28.96
52-wk Low
$11.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 18.53 25.80 14.73 --
Quarter Ending Jun-18 4 18.58 26.00 14.73 --
Year Ending Dec-18 7 67.91 104.60 44.11 51.37
Earnings (per share)
Quarter Ending Mar-18 4 -0.22 -0.01 -0.33 --
Quarter Ending Jun-18 4 -0.27 -0.08 -0.38 --
Year Ending Dec-18 8 -1.71 -0.42 -3.00 -2.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 26.31 110.72 5.77
Price to Book (MRQ) 15.16 13.56 5.41
Price to Tangible Book (MRQ) 16.00 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 76.32 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 225.95 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 5.62 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -209.53 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -206.33 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -206.33 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 22,602,121 855,667,832
Net Income/Employee (TTM) -797,026 2,968,747 100,655,557
Receivable Turnover (TTM) 103.37 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.11 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -26.13 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -81.04 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 85 53
13 Week 32.88 26.41 82 62
26 Week 25.44 15.90 73 77
52 Week 39.97 18.64 71 50
YTD 95.63 71.81 85 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.05%
# of Holders: 179
Total Shares Held: 36,123,755
3 Mo. Net Change: 5,783,416
# New Positions: 41
# Closed Positions: 14
# Increased Positions: 104
# Reduced Positions: 50
# Net Buyers: 54
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.